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IN breast  milk  and  paired  serum  from  70 lactating
women and 40 of their term, infection-free neonates,
on the 2nd and 5th day postpartum slCAM-1, sVCAM-
1,  sE-  and  sL-selectin  were  measured by ELISA  and
compared with those in 26 healthy adults (controls).
Seven infant formulas and fresh milk from five cows
were  also  analyzed.  Human  colostrum  values  of
slCAM-1, sVCAM-1 (similar to those in maternal and
control serum ), sE-selectin and sL-selectin (~10 and
~100  times  lower  than  in  maternal  and  control
serum ) were significantly higher than those in milk,
while  they  varied  widely.  None  of  the  adhesion
molecules was detected in fresh cow’s milk or infant
formulas. Exclusively breast-fed infants showed sig-
nificantly higher values of slCAM-1 and sL-selectin on
the 2nd day of life than those supplemented also with
formula.  Only  slCAM-1  values  correlated  positively
between  colostrum  and  time-matched  maternal
serum. These findings show in human milk impor-
tant  amounts of slCAM-1 and sVCAM-1 but  minimal
amounts of sE- and sL-selectin, which could affect the
immune system of the neonate.
Key words: Adhesion molecules, Breast milk, Colostrum,
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Introduction
It  is  widely  accepted  that  much  of  the  protective
effect of human milk is due not only to a direct-acting
antimicrobial  system  that  consists  of  humoral  and
cellular compounds but also to some immunomodula-
tory  and  immunoregulatory  agents.1 Among  them
proinflammatory  and  antiinflammatory  cytokines
have been extensively studied in the last 10 years.2–7
As regards soluble adhesion molecules, however, only
a  few  sporadic  references  on  soluble  intercellular
adhesion molecule-1 (slCAM-1), soluble vascular cell
adhesion molecule-1 (sVCAM-1) and soluble E-selectin
(sE-selectin) could be found in the literature.8–10 So
far, to the best of our knowledge, soluble L-selectin
(sL-selectin) has not been studied in human milk. For
this reason, the aim of this study was to evaluate the
presence of slCAM-1, sVCAM-1, sE- and sL-selectin in
human milk during the first days of lactation and to
examine  whether these adhesion molecules  are  an
intact part of the human breast milk immune system,
their putative origin, as well as their possible immuno-
modulatory effects on the development and matura-
tion of the neonatal immune system.
Materials and methods
Subjects and sample collection
This study was approved by the Institutional Review
Board for Human Research at our Teaching Hospital.
Maternal  informed  consent  was  also  obtained. All
participants  were  non-allergic,  healthy  lactating
women (n = 70) of mean age (range) 27.8 (19–40)
years  and  had  delivered  vaginally  (n =  53)  or  by
elective  cesarean  section  (n =  17)  single,  mature,
healthy,  appropriate  for  gestational  age  infants  (29
females/41  males),  after  full  term  (38.8  weeks,
37.0–42.0), uncomplicated pregnancies. Thirty-seven
of  them  were  nulliparous  and  the  remaining  33
multiparous.
A  peripheral  venous  blood  sample  and  a  milk
sample were collected on the 2nd and the 5th day
postpartum.  The  milk  samples  were  obtained  by
manual  expression,  just  after  venipuncture  for  the
blood  sample,  one  hour  after  last  feeding  in  the
morning. Furthermore, venous blood (~1ml) from 40
of their 70 neonates was also obtained simultaneously
with  blood  and  milk  sample  collection  from  their
mothers. Twelve neonates out of the 40 on the 2nd
day of life were exclusively breast fed, whereas the
remaining 28 were breast fed and supplemented with
bovine milk-based infant formula. On the 5th day of
life only 10 neonates were exclusively breast fed.
All neonates, lactating mothers and controls were
infection free as judged by clinical examination and
C-reactive  protein  (CRP)  values  (<3.5mg/L),  meas-
ured  in  the  same  blood  samples  as  adhesion
molecules.
Peripheral venous blood was also taken from 26 (15
females/11 males) healthy blood donors of mean age
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taking  any  medication  and  without  any  signs  of
infection  or  inflammation  for  the  last  3  months
(controls).
Moreover, fresh milk samples from five cows and
reconstituted, according to the manufacturing com-
pany  instructions,  samples  of  seven  different  pow-
dered cow’s milk-based infant formulas, used in the
Neonatal  Unit  of  our  Department  (Similac, Abbott;
Aptanyl, Milupa; Frisolac, Nounou; Almiron, Nutricia;
Premia, Bebelac; S-26, Wyeth; and Nativa, Karamole-
gos) were also analysed.
Preparation of serum and milk samples
Peripheral venous  blood  samples  were  obtained in
polypropylene pyrogen-free tubes and were kept at
5–8°C for clotting. Immediately after clotting, serum
was  separated by  centrifugation  in  two  steps  in  a
refrigerated  centrifuge  at  2500rpm  for  10min,  ali-
quoted  in  five  specimens  and  kept  at  –30°  until
assayed.
Milk specimens were collected also in pyrogen-free
tubes  and  they  were  refrigerated  immediately  at
2–5°C for two hours. Then they were centrifuged in
two  consecutive  steps,  2000rpm  for  10min  and
2500rpm for 15min at 6°C, to remove the cells and
lipid layer. The defatted and cell-free aqueous layer of
colostrum and  milk  samples was aspirated through
the  needle  of  a  sterilized  syringe  and  was  passed
through a special filter with pore diameter 0.45mm
(Minisart, Sartorius, Goetingen, Germany), to remove
any  last  membrane-associated  molecules  and  lipid
droplets. Then  cell-free  aqueous  fractions  were  ali-
quoted in small pyrogen-free tubes, and kept at –30°C
until assayed.
Adhesion molecule assays
Adhesion molecules slCAM-1,  sVCAM-1,  sE-  and  sL-
selectin  were  measured  by  sandwich-type  micro-
ELISAs, with commercially available reagents: Parame-
ter Human soluble ICAM-1 Immunoassay, Parameter
Human  soluble  VCAM-1  Immunoassay,  Parameter
Human soluble E-Selectin Immunoassay, and Parame-
ter  Human  soluble  L-Selectin  Immunoassay  (R&D
Systems, Minneapolis, MN, USA). The typical sensitiv-
ities  of  the  assays  were  0.35ng/ml  for  slCAM-1,
0.20ng/ml  for sVCAM-1, 0.106ng/ml  for  sE-selectin
and 0.30ng/ml for sL-selectin. These correspond to a
sample sensitivity equivalent to: 7.0ng/ml for slCAM-1
in serum and milk samples; 10ng/ml in serum and
5ng/ml in milk samples for sVCAM-1; 2.12ng/ml in
serum and 1.06ng/ml in milk samples for sE-selectin
and 30ng/ml in serum and 3.0ng/ml in milk samples
for sL-selectin, when the serum sample predilutions
were respectively 1:20, 1:50, 1:20 and 1:100 and the
milk sample predilutions were 1:20, 1:25, 1:10 and
1:10. The intra- and interassay coefficients of variation
(CV%) of the assays used were respectively 3.90% and
6.40%  for  slCAM-1,  4.50%  and  9.30%  for  sVCAM-1,
4.90% and 7.30% for sE-selectin and 3.75% and 10.35%
for sL-selectin. The validity of the assays for quantify-
ing  slCAM-1,  sVCAM-1,  sE-  and  sL-selectin  in  the
human  milk  was  tested  by  the  following  recovery
experiment. Five milk preparations (aqueous phase)
were divided in  two aliquots. Twenty-five,  50,  100,
200  and 400ng/ml of recombinant human slCAM-1
and sVCAM-1, 3, 6, 12, 25 or 50ng/ml sE-selectin and
5, 10, 20, 40, 80ng/ml sL-selectin were added. Each of
the four adhesion molecules was then quantified by
the respective microELISA. In addition to the endoge-
nous adhesion molecule measured in the preparation,
over 95% of the exogenously added quantity of slCAM-
1, sVCAM-1, sE- and sL-selectin were detected.
A serum,  colostrum  and transitional milk  sample
from every lactating woman as well as age-matched
serum samples of her neonate were analysed in the
same run.
Statistical analysis
For the statistical analysis of the results, the statistical
program Statgraphics,  version  1.0  (Manugistics  Inc,
Rockville, MD, USA) was used. The frequency distribu-
tion of slCAM-1, sVCAM-1, sE- and sL-selectin values in
neonatal, maternal  and  control  serum  was  normal,
while  that  in  milk  samples  was  not  (Kolmogorov-
Smyrnov test). For this reason, results in sera are given
as  mean  values  (±SD),  whereas  in  milk  as  median
values (upper and lower quartile). Data in serum were
analysed using parametric methods (Student’s t-test or
paired t-test, as appropriate, if natural pairing occured
in  experimental  series).  Comparisons  with  and
between  milk  samples  were  done  using  non-para-
metric methods: Wilcoxon test for unpaired measure-
ments  or  paired  Wilcoxon  test  (Wilkoxon  signed-
ranks  test),  as  appropriate.  Correlations  of  every
adhesion  molecule  values  between  colostrum  and
milk samples or between them and the time-matched
maternal or neonatal serum samples were examined
by  the  non-parametric  Spearman  rank  correlation
coefficient (rS), while between serum samples by the
parametric Pearson correlation coefficient (rP). The
effect  of  the  perinatal  factors,  mode  of  delivery,
maternal  age  and  parity  or  neonatal  gender  and
birthweight  on  every  adhesion  molecule  in  breast
milk, maternal or neonatal serum was examined by
multiple regression analysis.
A probability of p < 0.05 was taken as statistically
significant.
Results
Concentrations in box-plots of slCAM-1, sVCAM-1, sE-
and sL-selectin on the 2nd and 5th day postpartum in
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range) as well  as in time-matched sera (mean ±  SD,
range)  of  lactating  mothers  and  their  neonates  in
comparison with the respective values in controls are
depicted in Figs 1–4 respectively.
In colostrum (2nd  day of  life)  and human  transi-
tional breast milk (5th day):
d Important  amounts  of  slCAM-1  (520ng/ml;  253,
892; 43–1600 and 206.5ng/ml; 133, 300; 26–700,
respectively) and sVCAM-1 (223ng/ml; 158,  338;
48–1206, and 142ng/ml; 111, 187; 60–732, respec-
tively), while very low levels of sE-selectin (2.8ng/
ml:  1.9,  3.8;  0–11  and  1.2ng/ml;  1,  2;  0–6,
respectively) and sL-selectin (8.5ng/ml; 6.8, 12.5;
Soluble adhesion molecules in human milk
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FIG. 1. Values in box plots of soluble intercellular adhesion molecule-1 (sICAM-1) on the 2nd and 5th day postpartum in human
milk (d , median value; t , lower quartile; u , upper quartile; ? , minimum; > , maximum), and in time-matched sera (d , mean
value; t , –SD; u , +SD; ? , minimum; ? , maximum) of lactating mothers, and neonates in comparison with that in controls.
FIG. 2. Values in box plots of soluble vascular adhesion molecule-1 (sVCAM-1) on the 2nd and 5th day postpartum in human
milk (d , median value; t , lower quartile;u , upper quartile; ? , minimum; > , maximum), and in time-matched sera (d , mean
value; t , –SD; u ; +SD; ? , minimum; > , maximum) of lactating mothers, and neonates in comparison with that in controls.0.3–2.1, and 5ng/ml; 2, 7.5; 0–12.5, respectively)
are found.
d A  wide  variation  in  concentrations  of  all  four
studied adhesion molecules is observed.
d Values of slCAM-1, sVCAM-1, sE- and sL-selectin are
significantly higher on the 2nd than on the 5th day
postpartum  (p<1´ 10–7,  p<2´ 10–8,  p<1.5´ 10–11,
p<2.5´ 10–7, respectively).
d Colostrum  values  of  slCAM-1  are  significantly
higher than those in time-matched maternal serum
(256 ± 110ng/ml, 79–570; p<3´ 107) and controls
(243  ±  59ng/ml,  128–349;  p<0.0003),  while
human  milk  slCAM  does  not  differ  significantly
from controls, but is significantly lower than that in
time-matched maternal  serum  (287  ±  125ng/ml,
86–756; p<0.01).
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FIG. 3. Values in box plots of soluble E-selectin (sE-selectin) on the 2nd and 5th day postpartum in human milk (d , median
value; t , lower quartile; u , upper quartile; ? , minimum; > , maximum), and in time-matched sera (d , mean value; t , –SD; u ,
+SD; ? , minimum; > , maximum) of lactating mothers, and neonates in comparison with that in controls.
FIG. 4. Values in box plots of soluble L-selectin (sL-selectin) on the 2nd and 5th day postpartum in human milk (d , median
value; t , lower quartile; u , upper quartile; ? , minimum; > , maximum), and in time-matched sera (d , mean value; t , –SD; u ,
+SD; ? , minimum; > , maximum) of lactating mothers, and neonates in comparison with that in controls.d sVCAM-1 in both colostrum and transitional milk
was significantly lower than that in controls (516 ±
99ng/ml, 318–678; p<5´ 10–6) and time-matched
maternal serum (596 ± 280ng/ml, 263–1689; and
584  ±  242ng/ml,  264–1657;  respectively,
p<2´ 10–11).
d Colostrum and breast-milk sE-selectin is ~20  and
~40 times lower than that in controls (48 ± 13ng/
ml, 27–66) and ~10 and ~30 times lower than that
in time-matched maternal serum (32 ± 13.3ng/ml,
11–77 and 34 ± 14.8, 14–75, respectively).
d Colostrum and milk sL-selectin is ~100 times lower
in comparison with that in controls (938 ± 181ng/
ml, 656–1266) and time-matched maternal serum
(606 ± 207ng/ml, 306–1262; and 668 ± 205ng/ml,
318–1404, respectively).
Only concentrations of sICAM-1 on the 5th post-
partum day depend on the difficulty of milk expres-
sion.  Precisely,  significantly  higher  sICAM-1  values
were found on the 5th postpartum day in breast milk
samples  expressed  with  difficulty  (362ng/ml;  206,
460;  87–697)  compared  with  those  in  samples
expressed  easily  (197ng/ml;  124,  261;  26–573;
p<0.02).
In contrast with the presence of all four adhesion
molecules in human milk, in the bovine milk-based
formulas (n = 7) and in the fresh milk of five cows,
none  of  the  four  adhesion  molecules  studied  was
detected.
In maternal serum:
d Values of sICAM-1 and sVCAM-1 on both the 2nd
(256  ±  110ng/ml  and  596  ±  280ng/ml,  respec-
tively) and the 5th day postpartum (287 ± 125ng/
ml and 584 ± 242ng/ml respectively), showing no
significant change from the 2nd to 5th day post-
partum, do not differ significantly from the respec-
tive values in controls (243 ± 59ng/ml and 516 ±
99ng/ml).
d Values of sE- and sL-selectin on both the 2nd (32 ±
13.3ng/ml and 606 ± 207ng/ml, respectively) and
the 5th day postpartum (34 ± 14.8ng/ml and 668 ±
205ng/ml,  respectively)  are  significantly  lower
than the respective values in controls (48 ± 13ng/
ml, p<0.00002 and p<0.0005 and 938 ± 181ng/ml,
p<1´ 10–8 and p<1´ 10–6, respectively), showing a
significant  increase from  the 2nd to the 5th day
postpartum (p<0.01). Precisely, the increase is 9.15
± 2.58% (95% CI: 2.6–16.0) and 12.0 ± 3.3% (95%
CI: 3.63–20.3) respectively.
In neonatal serum:
d sICAM-1 values on the 2nd day of life (178 ± 50ng/
ml, 106–401) are significantly lower than those in
controls (243  ±  59ng/ml,  128–349;  p<0.00005),
whereas  on  the  5th  day  of  life  they  increase
significantly (230 ± 72ng/ml, 132–457; p<3´ 10–7),
reaching control values.
d sVCAM-1 and sE-selectin values on both the 2nd
day  (1494  ±  371ng/ml  and  139  ±  48ng/ml,
respectively) and the 5th day of life (1671 ± 439ng/
ml  and  111  ±  35ng/ml,  respectively)  are  highly
elevated  compared  with  those  in  controls
(p<4´ 10–11 and p<5´ 10–10 respectively) and lactat-
ing mothers.
d From the 2nd to the 5th day of life a significant rise
was observed in sVCAM-1 values (p<0.005)  but a
significant fall in sE-selectin values (p<1´ 10–7).
d sL-selectin values on both the 2nd (674 ± 213ng/
ml) and the 5th day of life (684 ± 221ng/ml) are
lower  than  those  in  controls  (938  ±  181ng/ml;
p<0.001  and  p<0.003,  respectively),  showing  no
significant change from the 2nd to the 5th day of
life.
d The  neonates  exclusively  breast  fed  show  sig-
nificantly  higher  values  of  sICAM-1  (263.9  ±
76.7ng/ml) and sL-selectin (761.4  ± 232.7ng/ml)
compared with those in neonates breast fed and
supplemented  with  cow’s  milk-based  formula
(187.10  ±  30.34ng/ml;  p<0.006  and  545.5  ±
187.6ng/ml; p<0.02, respectively).
The  study  of  correlations  of  the  four  adhesion
molecules in breast milk, maternal and neonatal age-
matched serum samples revealed that:
d Between  colostrum  on  the  2nd  and  transitional
milk on the 5th day postpartum there is a positive
correlation  in  sICAM  or  sL-selectin  values
(rs=0.316; p<0.02 or rs=0.430; p<0.00001 respec-
tively)  and  a  strong  correlation  in  sVCAM-1
(rs=0.700;  p<0.00001)  or  sE-selectin  values
(rs=0.862; p<0.00001).
d A  positive  correlation  is  also  observed  between
slCAM-1 and sVCAM-1 values in human colostrum
(rs=0.342; p<0.01)  but in breast milk on the 5th
day  postpartum  a  negative  correlation  between
sICAM-1  and  sE-selectin  values  (rs=–0.270;
p<0.03).
d A positive correlation is also noticed in  sICAM-1
values  between  colostrum  on  the  2nd  day  post-
partum and time-matched maternal serum samples
(rs=0.306; p<0.02).
d Between maternal serum samples on the 2nd and
5th day postpartum values of sICAM-1, sVCAM-1,
sE-  or  sL-selectin  are  correlated  rather  strongly
(rp=0.607, rp=0.687, rp=0.856 or rp=0.507, respec-
tively; p<0.00001).
d A negative correlation is noticed between sVCAM-1
and sE-selectin values in maternal serum samples
on the 5th postpartum day (rp=–0.320, p<0.01).
d A  positive  correlation  is  observed  in  sE-selectin
values between maternal and neonatal serum  on
the 5th postpartum day (rP=0.386, p<0.05).
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5th day of life strong correlations were noticed in
sICAM-1,  sVCAM-1,  sE-  and  sL-selectin  values
(rP=0.788,  rP=0.725,  rP=0.885  and  rP=0.813,
respectively; p<0.00001).
d A positive correlation was also noticed between:
(a)  sICAM-1  and  sL-selectin  values  in  neonatal
serum samples on both the 2nd or the 5th day of
life  (rP=0.491;  p<0.002  or  rP=0.476;  p<0.008
respectively) and (b) sVCAM-1 and sE-selectin or sL-
selectin values in neonatal serum only on the 5th
day  of  life  (rP=0.359;  p<0.045  or  rP=0.435;
p<0.015, respectively).
The study of the effect of several perinatal factors
on the cell adhesion molecule values in breast milk,
maternal serum and neonatal serum showed that:
d Values of sICAM-1, sVCAM-1, sE- and sL-selectin on
either the 2nd or the 5th day postpartum are not
dependent on the mode of delivery, maternal age
or parity, neonatal gender or birthweight.
Discussion
In  this  study  we  measured  the  serum  adhesion
molecules sICAM-1, VCAM-1, sE- and sL-selectin in the
defatted  and  acellular  aqueous  phase  of  human
colostrum and transitional milk during the first days of
lactation. Our findings reveal that (a) colostrum and
transitional  milk  contain  important  amounts  of
sICAM-1  and  sVCAM-1  but  minimal  amounts of SE-
and  SL-selectin,  (b)  significantly  higher  concentra-
tions  of  all  four  adhesion  molecules  are  found  in
human  colostrum  on  the  2nd  day  compared  with
those in milk samples on the 5th day portpartum and
(c) all four adhesion molecules studied present large
variations in their concentrations in both colostrum
and milk samples. Similar results have been reported
for  sICAM-1,  sVCAM-1  and  sE-selectin  in  a  small
number of human colostrum (n = 10) and milk (n =
13) samples and for  sICAM-1 only in  a very recent
report13 and  an  abstract.12 To  the  best  of  our
knowledge sL-selectin in human milk that we detec-
ted in 90% of the human colostrum samples and 80%
of the transitional milk samples is reported here for
the first time.
The  significantly  lower  human  milk  content  in
adhesion molecules than that in colostrum led some
investigators to suggest that sICAM-1, sVCAM-1 and
sE-selectin were unlikely to contribute significantly in
human milk’s anti-inflammatory effects.13 We believe,
however, that the important amounts of sICAM-1 and
sVCAM-1 in colostrum from the 2nd day postpartum
suggest that at least these compounds could affect the
recipient infant, particularly in the first days of life.
On the other hand, the significantly higher concentra-
tions  of  all  four  adhesion  molecules  in  human
colostrum  (2nd  day)  compared  with  those in  milk
(5th day postpartum), as well as the higher concentra-
tions of sICAM-1 in colostrum than in controls and
lactating  mothers, seem  to  be  in  analogy  with  the
protein content of human colostrum and later breast
milk,  like  albumin,  protein  hormones,  and  growth
factors.14,15
During  the  first  24hr  postpartum  the  colostrum
production is ~120mL, whereas on the 5th day the
total  volume/day  of  transitional  milk  reaches
~250–300mL.16 Consequently,  the  total  amount  of
sICAM-1/day  in  colostrum  should  be  ~5000  to
187500ng/day, considering that concentrations range
from  40  to  1500ng/ml,  while  on  the  5th  day
postpartum  the  total  amount  in  milk  should  be
~6500–175000ng/day,  considering  that  concentra-
tions range from 26 to 700ng/ml. Regarding even sL-
selectin, the respective content of colostrum per day
should be 850–1560ng and that in milk 500–1875ng/
day,  considering that  the  respective concentrations
were  6.8–12ng/ml  and  2–7.5ng/ml,  respectively.
Hence,  we  consider  that  physiologically  important
amounts per day of all four adhesion molecules are in-
taken by newborn infants through breast-feeding and
could  potentially  act  as  immunomediators8,10 or
angiogenetic17 and maturational agents. They might
protect the newborn against infections of respiratory
and intestinal tract and suppress certain diseases such
as atopy, coelial disease18 and inflammatory diseases
of the neonatal gut during the first days of life, when
there  is  increased  risk  of  overshooting  immune
reactions, leading maybe to chronic inflammation, as
proposed  for  certain  cytokines  and  their  soluble
receptors.6,9,13 They could also promote the growth,
differentiation  and  maturation  of  very  important
neonatal  tissues  like  gut  and  lung,  and  induce
developmental  and  maturational  processes  of  the
immune  system  in  neonates,  similarly  to  milk  hor-
mones, cytokines and growth factors.3,6,7,19
sICAM-1  and  sVCAM-1,  found  in  human  milk  in
considerable amounts, do  not differ  significantly  in
maternal serum from those in controls. In contrast, sE-
and sL-selectin, which show very low concentrations
in  human  milk,  present  in  maternal  serum  sig-
nificantly  lower  concentrations  than  those  in  con-
trols. Matthiesen et al. have suggested that a state of
systemic suppression of the maternal immune system
seems to be present during pregnancy and the early
postnatal period.20
Values of soluble cell adhesion molecules in human
milk  were  compared  and  correlated with  those  in
time-matched  maternal  serum  in  order  to  get  an
indication  of  the  origin  of  these  biomolecules  in
human  milk.  However,  for  sICAM-1  values  only,  a
significant  positive  trend  between  colostrum  and
time-matched maternal serum was noticed, similarly
to  a  previous  study.13 Thus,  it  appears  that  only
sICAM-1  could  be  derived at  least  partially  directly
from  maternal  circulation.  Possible  sources  of  the
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cellular  components  such  as  leukocytes,  macro-
phages, some T cells, vascular or epithelial cells found
abundantly epecially in early milk. This latter observa-
tion is probably an explanation of the higher values in
colostrum than in transitional milk. They could also
derive  from  the  cellular  activity  of  the  mammary
gland itself, where components such as IgA, complex
proteins and carbohydrates are synthesized. Further
studies are needed to explore this hypothesis.
Our  finding  of  a  significant  positive  correlation
between sICAM-1 and sVCAM-1 in colostrum is not in
agreement with the results of a previous report;11 this
may be due to the very small number of the colostrum
samples they analysed.
The low human milk content of selectins might be
attributed to  the  transient expression  of  E-selectin,
which  peaks  and  begins  to  decline  before  the
appearance of CD35+ cells.10
In contrast with our results showing that all four
adhesion  molecules  were  found  in  human  milk  in
quantities similar to (slCAM-1 and sVCAM-1), or less
than (sE-selectin, sL-selectin) those in control serum,
none  of  the  four  adhesion  molecules  could  be
detected in the reconstituted seven different bovine
milk-based formulas, or in the fresh milk samples of
five cows, treated with exactly the same protocol as
human  milk  samples. It is possible that cow’s milk
contains adhesion molecules with different epitopes
than those in human breast milk, and consequently
they cannot be detected with the microELISAs used,
with antibodies specific against recombinant human
adhesion molecules.  For  this  reason, it  is  apparent
that  the  beneficial  effects  of  breast-feeding  to  the
recipient child are lacking, when the newborn infants
are formula-fed.
Similarly to previous reports21–26 the results of the
present study on slCAM-1, sVCAM-1 and sE- and sL-
selectin in the serum of healthy term neonates show
the following. First, shedding of slCAM-1, sVCAM-1,
sE- and sL-selectin is an established component of the
immune  system  of  the  newborn  infant  from  birth.
Second, the increase of postnatal age has a positive
effect on the neonatal serum slCAM-1 and sVCAM-1,
suggesting  an  expansion  of  the  neonatal  immune
system  and  response.  Breast-feeding  seems  to  be
beneficial  to  this  expansion  and  maturation of  the
immune system considering the elevated concentra-
tions  in  human  milk  of  the  latter  two  adhesion
molecules.  Third,  the  highly  elevated  neonatal
sVCAM-1  and  sE-selectin  values,  as  also  reported
previously,24–26 might  be  attributed to  their  strong
angiogenic  function,17 considering  that  in  the  pre-
natal period intense angiogenesis is noticed. Finally, in
the  early  neonatal  period,  sL-selectin  values  were
significantly lower then in healthy adults, due possibly
to the well-known functional immaturity of neonatal
leucocytes,  characterized by  diminished  expression
of  L-selectin  and  impaired  shedding  of  sL-
selectin.27,28
The  finding  in  the  present  study  of  significantly
higher  slCAM-1  and  sL-selectin  values  in  neonates
exclusively breast-fed than in neonates supplemented
also  with  cow’s-milk  formula,  suggests  that  breast-
feeding,  at  least  in  the  very  early  neonatal  period,
offers the recipient newborn infant what it is lacking,
since  these  two  molecules  show  lower  neonatal
values than those in healthy controls.
In conclusion, the findings of this study reconfirm
the  presence  of  slCAM-1,  sVCAM-1  and  sE-selectin,
reveal that of sL-selectin in human milk in the early
lactation period and indicate that all  four  adhesion
molecules are physiologically important constituents
of  human breast milk  in the very early postpartum
period. This  suggests  potential  immunomodulatory
and anti-inflammatory effects of breast-feeding on the
recipient newborn infant, as well as the promotion of
maturation, development and expansion of the neona-
tal  immune  systems.  Only  slCAM-1  in  human  milk
seems to derive, at least partially, from the maternal
circulation,  while  for  the  origin  of  the  remaining
three adhesion molecules only  putative suggestions
may be proposed.
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